Samuel Hasson

Samuel Hasson is a Senior Director at Rgenta Therapeutics Inc., with a robust background in drug discovery and functional genomics, particularly focused on neurodegenerative diseases. Previous positions include Associate Director at Voyager Therapeutics, Inc., Senior Scientist at Amgen, and Principal Investigator at Pfizer. Samuel's academic journey began with a PhD in Biochemistry & Molecular Biology from UCLA, following a BA in Molecular Biology from Pitzer College. Early career experiences include significant roles at the National Institutes of Health and the University of California, Los Angeles, where foundational research in mitochondrial biology and high-throughput screening was conducted. Samuel has garnered extensive expertise in therapeutic development and target identification for Parkinson's disease.